{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:45:31Z","timestamp":1776872731168,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221421"],"award-info":[{"award-number":["BK20221421"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12072-024-10715-0","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T14:02:37Z","timestamp":1723471357000},"page":"1555-1565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-2573","authenticated-orcid":false,"given":"Huilian","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinlei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"10715_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cld.2023.06.006","volume":"28","author":"H Inbal","year":"2024","unstructured":"Inbal H, Hirschfield GM. Primary biliary cholangitis: pathophysiology. Clin Liver Dis. 2024;28:79\u201392","journal-title":"Clin Liver Dis"},{"key":"10715_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cld.2023.06.005","volume":"28","author":"MS Faisal","year":"2024","unstructured":"Faisal MS, Gonzalez HC, Gordon SC. Primary biliary cholangitis: epidemiology, diagnosis, and presentation. Clin Liver Dis. 2024;28:63\u201377","journal-title":"Clin Liver Dis"},{"key":"10715_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145\u2013172","journal-title":"J Hepatol"},{"key":"10715_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","volume":"128","author":"C Corpechot","year":"2005","unstructured":"Corpechot C, Carrat F, Bahr A, et al. The efect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005;128:297\u2013303","journal-title":"Gastroenterology"},{"key":"10715_CR5","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10620-021-07165-1","volume":"67","author":"Z Shuo","year":"2022","unstructured":"Shuo Z, Xixi T, Li W, et al. Downregulation of programmed death-1 pathway promoting CD8 + T cell cytotoxicity in primary biliary cholangitis. Dig Dis Sci. 2022;67:2981\u20132993","journal-title":"Dig Dis Sci"},{"key":"10715_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"D Michael","year":"2021","unstructured":"Michael D, Dominik P, Sainitin D, et al. Auto-aggressive CXCR6 CD8 T cells cause liver immune pathology in NASH. Nature. 2021;592:444\u2013449","journal-title":"Nature"},{"key":"10715_CR7","doi-asserted-by":"publisher","first-page":"1095915","DOI":"10.3389\/fimmu.2022.1095915","volume":"13","author":"G Haoxian","year":"2022","unstructured":"Haoxian G, Shenglu L, Linxin L, et al. Obeticholic acid and 5\u03b2-cholanic acid 3 exhibit anti-tumor effects on liver cancer through CXCL16\/CXCR6 pathway. Front Immunol. 2022;13:1095915","journal-title":"Front Immunol"},{"key":"10715_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69:394\u2013419","journal-title":"Hepatology"},{"key":"10715_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouilleres O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55:1361\u20131367","journal-title":"J Hepatol"},{"key":"10715_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978;379:103\u2013112","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10715_CR11","doi-asserted-by":"publisher","first-page":"110801","DOI":"10.1016\/j.nut.2020.110801","volume":"77","author":"H Meng","year":"2020","unstructured":"Meng H, Zhu L, Kord-Varkaneh H, Santos HO, Tinsley GM, Fu P. Effects of intermittent fasting and energy-restricted diets on lipid profile: a systematic review and meta-analysis. Nutrition. 2020;77:110801","journal-title":"Nutrition"},{"issue":"4","key":"10715_CR12","first-page":"428","volume":"46","author":"Y Treister-Goltzman","year":"2021","unstructured":"Treister-Goltzman Y, Yarza S, Peleg R. Lipid profile in mild subclinical hypothyroidism: systematic review and meta-analysis. Minerva Endocrinol (Torino). 2021;46(4):428\u2013440","journal-title":"Minerva Endocrinol (Torino)"},{"issue":"1","key":"10715_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69(1):394\u2013419","journal-title":"Hepatology"},{"key":"10715_CR14","doi-asserted-by":"publisher","first-page":"103485","DOI":"10.1016\/j.autrev.2023.103485","volume":"23","author":"RH Nanjundappa","year":"2023","unstructured":"Nanjundappa RH, Shao K, Krishnamurthy P, et al. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications. Autoimmun Rev. 2023;23:103485","journal-title":"Autoimmun Rev"},{"key":"10715_CR15","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/jcmm.14752","volume":"24","author":"S-X Zhao","year":"2020","unstructured":"Zhao S-X, Li W-C, Fu N, et al. Emperipolesis mediated by CD8 T cells correlates with biliary epithelia cell injury in primary biliary cholangitis. J Cell Mol Med. 2020;24:1268\u20131275","journal-title":"J Cell Mol Med"},{"key":"10715_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097701","volume":"9","author":"H Kira","year":"2014","unstructured":"Kira H, Friederike R, Val\u00e9a S, et al. The function of the chemokine receptor CXCR6 in the T cell response of mice against Listeria monocytogenes. PLoS ONE. 2014;9: e97701","journal-title":"PLoS ONE"},{"key":"10715_CR17","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/infdis\/jiu281","volume":"210","author":"S-W Tse","year":"2014","unstructured":"Tse S-W, Radtke AJ, Espinosa DA, et al. The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8\u207a T cells specific for infectious pathogens. J Infect Dis. 2014;210:1508\u20131516","journal-title":"J Infect Dis"},{"key":"10715_CR18","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1053\/j.gastro.2019.01.247","volume":"156","author":"JC Mossanen","year":"2019","unstructured":"Mossanen JC, Kohlhepp M, Wehr A, et al. CXCR6 inhibits hepatocarcinogenesis by promoting natural killer T- and CD4 T-cell-dependent control of senescence. Gastroenterology. 2019;156:1877-1889.e4","journal-title":"Gastroenterology"},{"key":"10715_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3892\/or.2012.2185","volume":"29","author":"K Ji-Ye","year":"2013","unstructured":"Ji-Ye K, Aya I, Shozo H, et al. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model. Oncol Rep. 2013;29:975\u2013982","journal-title":"Oncol Rep"},{"key":"10715_CR20","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1016\/j.apsb.2022.03.012","volume":"12","author":"Li Tingting","year":"2022","unstructured":"Tingting Li, Jie P, Hongqi C, et al. CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction. Acta Pharm Sin B. 2022;12:3255\u20133262","journal-title":"Acta Pharm Sin B"},{"key":"10715_CR21","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1158\/0008-5472.CAN-11-4032","volume":"72","author":"G Qiang","year":"2012","unstructured":"Qiang G, Ying-Jun Z, Xiao-Ying W, et al. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Res. 2012;72:3546\u20133556","journal-title":"Cancer Res"},{"issue":"6","key":"10715_CR22","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jhep.2021.01.013","volume":"74","author":"JM Schattenberg","year":"2021","unstructured":"Schattenberg JM, Pares A, Kowdley KV, Heneghan MA, Caldwell S, Pratt D, et al. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. J Hepatol. 2021;74(6):1344\u20131354","journal-title":"J Hepatol"},{"issue":"4","key":"10715_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/jgh.14900","volume":"35","author":"K Takano","year":"2020","unstructured":"Takano K, Saeki C, Oikawa T, Hidaka A, Mizuno Y, Ishida J, et al. IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate. J Gastroenterol Hepatol. 2020;35(4):663\u2013672","journal-title":"J Gastroenterol Hepatol"},{"key":"10715_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15151","volume":"27","author":"Li Yixuan","year":"2024","unstructured":"Yixuan Li, Jing W, Huan J, et al. Causal association between autoimmune liver disease and Sj\u00f6gren\u2019s syndrome: A Mendelian randomization study. Int J Rheum Dis. 2024;27: e15151","journal-title":"Int J Rheum Dis"},{"issue":"29","key":"10715_CR25","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.3748\/wjg.v27.i29.4890","volume":"27","author":"V Guatibonza-Garc\u00eda","year":"2021","unstructured":"Guatibonza-Garc\u00eda V, Gaete PV, P\u00e9rez-Londo\u00f1o A, Puerto-Baracaldo DK, Guti\u00e9rrez-Romero SA, Mendivil CO, et al. Poor performance of anti-mitochondrial antibodies for the diagnosis of primary biliary cholangitis in female Colombian patients: a single-center study. World J Gastroenterol. 2021;27(29):4890\u20134899","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10715_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12072-021-10267-7","volume":"16","author":"S Chen","year":"2022","unstructured":"Chen S, Lv T, Sun G, et al. Reciprocal alterations in circulating and hepatic gamma-delta T cells in patients with primary biliary cholangitis. Hepatol Int. 2022;16(1):195\u2013206","journal-title":"Hepatol Int"},{"key":"10715_CR27","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3389\/fimmu.2019.02633","volume":"10","author":"TJ Hydes","year":"2019","unstructured":"Hydes TJ, Blunt MD, Naftel J, et al. Constitutive activation of natural killer cells in primary biliary cholangitis. Front Immunol. 2019;10:2633","journal-title":"Front Immunol"},{"key":"10715_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bbadis.2018.11.020","volume":"1865","author":"L Anke","year":"2019","unstructured":"Anke L, Alexander W, Marlene K, et al. CXCR6 protects from inflammation and fibrosis in NEMO mice. Biochim Biophys Acta Mol Basis Dis. 2019;1865:391\u2013402","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10715_CR29","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","volume":"190","author":"W Alexander","year":"2013","unstructured":"Alexander W, Christer B, Felix H, et al. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis. J Immunol. 2013;190:5226\u20135236","journal-title":"J Immunol"},{"issue":"1","key":"10715_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12876-021-01974-4","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hu X, Chang J, et al. The liver steatosis severity and lipid characteristics in primary biliary cholangitis. BMC Gastroenterol. 2021;21(1):395","journal-title":"BMC Gastroenterol"},{"key":"10715_CR31","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374:6474","journal-title":"Science"},{"issue":"13","key":"10715_CR32","doi-asserted-by":"publisher","first-page":"1099385","DOI":"10.3389\/fonc.2023.1099385.PMID:37593098;PMCID:PMC10430781","volume":"1","author":"X Li","year":"2023","unstructured":"Li X, Gao Z, Chen J, Feng S, Luo X, Shi Y, et al. Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma. Front Oncol. 2023;1(13):1099385. https:\/\/doi.org\/10.3389\/fonc.2023.1099385.PMID:37593098;PMCID:PMC10430781","journal-title":"Front Oncol"},{"key":"10715_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2021-003100","volume":"9","author":"B Wang","year":"2021","unstructured":"Wang B, Wang Y, Sun X, Deng G, Huang W, Wu X, et al. CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell. J Immunother Cancer. 2021;9:1\u201313","journal-title":"J Immunother Cancer"},{"key":"10715_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister D, N\u00fa\u00f1ez NG, Pinyol R, et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. 2021;592:450\u2013456","journal-title":"Nature"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10715-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T15:08:37Z","timestamp":1728400117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10715-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10715"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10715-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4426292\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Huilian Shi, Xiangtao Xu, Shuangshuang Wang, Qinlei Chen, Fan Zhang, Haiyan Guo, Weiting Lu and Fei Qiao declare that they have no conflict interests associated with the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The ethics committee of the Affiliated Hospital of Nanjing University of Chinese Medicine reviewed and approved the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all subjects enrolled in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}